GlassScriptPhysician profile
James Patrick Mcdonald
NPI 1659812824
$1,107.56
in general payments reported to CMS, 2019-2025
16 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.23 · 2022: $27.71 · 2023: $518 · 2024: $322 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $318.76 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Triclip, Amplatzer Amulet |
| Astrazeneca Pharmaceuticals LP | $231.70 | 2023-2024 | Breztri, Airsupra, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $129.34 | 2023-2025 | Lifevest |
| Cordis US Corp. | $80.88 | 2023-2025 | Mynx Control Venous, Mynx Venous Vcd, Rain Sheath Transradial |
| E.R. Squibb & Sons, L.L.C. | $61.79 | 2024 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $40.06 | 2023-2024 | Xarelto |
| Pfizer INC. | $35.88 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $34.29 | 2023 | |
| Merck Sharp & Dohme LLC | $32.29 | 2023 | Verquvo |
| Bridgebio Pharma, INC. | $29.77 | 2025 | Attruby |
| Boston Scientific Corporation | $26.45 | 2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.25 | 2023 | Jardiance |
| Esperion Therapeutics, INC. | $16.29 | 2023 | Nexletol |
| Amgen INC. | $15.95 | 2023 | Repatha |
| Philips North America LLC | $12.89 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sensible Medical Innovations INC | $6.15 | 2024 | Reds System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.